Carboximidamides
TARGETMOL CHEMICALS INC CP 461 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg 500 mg and bulk. Please contact Fisher for quotes. CP 461 (UNII-68OJX9I7DT) a specific PDE2A inhibitor is a novel pro-apoptotic compound that inhibits cyclic GMP phosphodiesterase but not cyclooxygenase-1 or -2. CP 461 inhibits the growth of a variety of human tumor cell lines in vitro and selectively induces apoptosis in cancer cell lines but not in normal cells. purity: 99%
Sigma Organic Chemistry N(alpha), N-(im)-Di-Boc-L-histidine methyl ester | 5G | 17791-51-4 | MFCD03094049 | 0.97
N(alpha), N-(im)-Di-Boc-L-histidine methyl ester | 5G | 17791-51-4 | MFCD03094049 | 0.97
Sigma Aldrich Fine Chemicals Biosciences Agar ash 2.0 4.55KG
Agar is a polysaccharide consisting of - D-galactopyranosyl and 3 6-anhydro -L- galactopyranosyl units. Depending on the source agar exists as various substituted forms such as methyl and sulphate ether. It is a linear galactan polysaccharide isolated from the cell wall of Rhodophyceae class of seaweeds.
Sigma Aldrich Fine Chemicals Biosciences Agar ash 2.0 4.55KG
Agar is a polysaccharide consisting of - D-galactopyranosyl and 3 6-anhydro -L- galactopyranosyl units. Depending on the source agar exists as various substituted forms such as methyl and sulphate ether. It is a linear galactan polysaccharide isolated from the cell wall of Rhodophyceae class of seaweeds.
Sigma Organic Chemistry Selenourea | 10G | 630-10-4 | MFCD00008065
CAS #: 630-10-4
MDL #: MFCD00008065
Purity: >98 %
UNSPSC Code: 12352100
Molecular Weight: 123.02
Sigma Organic Chemistry Selenourea | 1G | 630-10-4 | MFCD00008065
CAS #: 630-10-4
MDL #: MFCD00008065
Purity: >98 %
UNSPSC Code: 12352100
Molecular Weight: 123.02
Sigma Organic Chemistry O-Methylisourea hemisul | 100G | 52328-05-9 | MFCD00040594
O-Methylisourea hemisul , 100G
About this item:
CAS #: 52328-05-9
MDL #: MFCD00040594
Purity: ≥99
Molecular Weight: 123.12
UNSPSC Code: 12352100
Sigma Aldrich Fine Chemicals Biosciences Metformin Impurity A | 461-58-5 | MFCD00008066 | 25mg
Metformin Impurity A | Mol Wt: 84.08 | 461-58-5 | MFCD00008066 | 25mg
Medchemexpress LLC Benzamidine hydrochloride | 1670-14-0 | 156.61 g/mol |
Benzamidine hydrochloride | 1670-14-0 | 156.61 g/mol |
Sigma Organic Chemistry Allantoin | 100G | 97-59-6 | MFCD00005260
CAS #: 97-59-6
MDL #: MFCD00005260
Purity: 98% (N)
UNSPSC Code: 12352100
Molecular Weight: 158.12
Selleck Chemical LLC Creatine monohydrate
Creatine (Methylguanidoacetic acid) is a key player in the phosphagen energy system the primary source of ATP during short-term high intensity activities
Apexbio Technology LLC MRTX-1133 1MG
MRTX-1133 (CAS 2621928-55-8) is a non-covalent alkyne-based inhibitor specifically targeting the KRAS G12D mutant protein It binds KRAS G12D with sub-picomolar affinity occupying the Switch II pocket and forming multiple intermolecular interactions Through these interactions MRTX-1133 disrupts SOS1-mediated guanine nucleotide exchange and prevents the assembly of KRAS-GTP/RAF1 signaling complexes thereby inhibiting downstream KRAS-driven signaling pathways MRTX-1133 is applied in cancer biology research to investigate tumor signaling and therapeutic strategies involving KRAS G12D mutations
Apexbio Technology LLC MYK-461 1642288-47-8 25mg
MYK-461 is a small-molecule inhibitor interacting directly with cardiac myosin heavy chain to modulate myocardial contraction It specifically reduces myocardial contractility through inhibition of cardiac myosin ATPase enzymatic activity thereby limiting myosin-mediated phosphate release without affecting ADP dissociation rates In rodent cardiomyocytes MYK-461 demonstrates dose-dependent reductions in fractional shortening and sarcomeric force generation without impacting calcium transient dynamics Its inhibitory potency against cardiac myosin ATPase surpasses that observed for skeletal muscle isoforms In preclinical hypertrophic cardiomyopathy mouse models MYK-461 administration attenuates cardiac contractile function facilitating investigations into myocardial contractility regulation and potential therapeutic strategies against hypertrophic cardiomyopathy